Y-mAbs Therapeutics (NASDAQ:YMAB) lost ~6% on Tuesday after Bank of America downgraded the cancer drug ... he lowered his price target on the stock to $3 from $12 per share, arguing that most ...

24/7 Wall St. has analyzed the stock, industry, sector and the macro environment to forecast where shares of Bank of America could be heading over the next five years. After reaching its five ...

That's a very high hurdle that no stock can clear, in my opinion. Bank of America is an advertising partner of Motley Fool Money. Neil Patel and his clients have no position in any of the stocks ...

Bank of America downgraded Pepsi (PEP ... The bank's price target on PEP stock sank to $155 from $185. The Recent Price Action of PEP Stock In the last month, the shares have dropped 2.5% ...

Ooops... Something went wrong while loading this page.

Bank of America analysts gave the snack and beverage giant a 'neutral' rating Tuesday and slashed their price target.

Bank of America topped expectations, fueled by strong consumer and trading results. Management's upbeat tone despite a flurry of worrisome headlines about the economy is helping fuel the stock's ...

If so, Bank of America might prove to be a good safe-harbor candidate for investors worried about turbulence up ahead. Before you buy stock in Bank of America, consider this: The Motley Fool Stock ...